Skip to main content

Peer Review reports

From: Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries

Original Submission
8 Sep 2022 Submitted Original manuscript
13 Oct 2022 Reviewed Reviewer Report
15 Oct 2022 Reviewed Reviewer Report
15 Nov 2022 Reviewed Reviewer Report
16 Dec 2022 Author responded Author comments - Sarwat Mahmud
Resubmission - Version 2
16 Dec 2022 Submitted Manuscript version 2
21 Dec 2022 Reviewed Reviewer Report
13 Jan 2023 Reviewed Reviewer Report
29 Jan 2023 Reviewed Reviewer Report
24 Feb 2023 Author responded Author comments - Sarwat Mahmud
Resubmission - Version 3
24 Feb 2023 Submitted Manuscript version 3
7 Mar 2023 Author responded Author comments - Sarwat Mahmud
Resubmission - Version 4
7 Mar 2023 Submitted Manuscript version 4
Publishing
10 Mar 2023 Editorially accepted
11 Apr 2023 Article published 10.1186/s12916-023-02827-5

You can find further information about peer review here.

Back to article page